Leerink Partnrs Has Negative Outlook of VKTX FY2025 Earnings
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Viking Therapeutics in a research note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the biotechnology company will earn ($1.74) per share for the year, down from their previous estimate […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Viking Therapeutics in a research note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the biotechnology company will earn ($1.74) per share for the year, down from their previous estimate […]
